Advertisement
Loading...

CSL Limited

CMXHF•PNK
Healthcare
Biotechnology
$71.61
$2.61(3.78%)
U.S. Market is Open • 15:41

CSL Limited (CMXHF) Stock Overview

Explore CSL Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap32.8B
P/E Ratio23.01
EPS (TTM)$6.17
ROE0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$94.37
3 Months$96.61
1 Year Target$105.96

CMXHF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CSL Limited (CMXHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 25.95, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $105.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.01 and a market capitalization of 32.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.71%
5-Day Change
-3.51%
1-Month Change
-29.69%
3-Month Change
-36.00%
6-Month Change
-40.44%
Year-to-Date (YTD) Change
-40.69%
1-Year Change
-57.97%
3-Year Change
-66.15%
5-Year Change
-68.28%
All-Time (Max) Change
2456.25%

Contact Information

https://www.csl.com.au
61 3 9389 1911
45 Poplar Road, Melbourne, VIC, 3052

Company Facts

32,698 Employees
IPO DateNov 18, 2005
CountryAU
Actively Trading

Frequently Asked Questions